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Preclinical studies indicate that focused ultrasound at exposure conditions close to the threshold for thermal damage can increase
drugdeliveryatthefocalregion.Althoughtheseresultsarepromising,theoptimalcontroloftemperaturestillremainsachallenge.
Toaddressthisissue,computer-simulatedultrasoundtreatmentshavebeenperformed.Whenthetreatmentsaredeliveredwithout
taking into account the cooling eﬀect exerted by the blood ﬂow, the resulting thermal dose is highly variable with regions of
thermal damage, regions of underdosage close to the vessels, and areas in between these two extremes. When the power deposition
is adjusted so that the peak thermal dose remains close to the threshold for thermal damage, the thermal dose is more uniformly
distributedbutunder-dosageisstillvisiblearoundthethermallysigniﬁcantvessels.Theresultsofthesesimulationssuggestthat,for
focused ultrasound, as for other delivery methods, the only way to control temperature is to adjust the average energy deposition
to compensate for the presence of thermally signiﬁcant vessels in the target area. By doing this, we have shown that it is possible to
reduce the temperature heterogeneity observed in focused ultrasound thermal treatments.
1.Introduction
Local temperature elevation (hyperthermia) has been inves-
tigated for the treatment of many kinds of cancer for several
years [1–5]. Early clinical trials that took place in the 1990s
pointed out challenges associated with thermal therapies
such as diﬃculty in reaching most tumor sites. For the lim-
ited number of sites that were heatable, dosimetric studies
indicated that the temperature distributions reached were
highly inhomogeneous and that it was almost impossible to
obtain the protocol temperature goals [6, 7]. Accordingly,
it is generally believed that the most beneﬁcial contribution
of hyperthermia for cancer treatment is based on enhancing
the eﬀectiveness of other treatment modalities such as radio-
therapy or chemotherapy [8]. As a matter of fact, several
clinical studies have shown a statistically signiﬁcant tumor
control when hyperthermia is combined with radiotherapy,
chemotherapy, or both [9, 10]. Recent studies have indicated
that this beneﬁt may arise in part from heat-induced sensiti-
zation of cancer stem or tumor initiating cells to radiation or
chemotherapy [11].
In the ﬁeld of ultrasound hyperthermia, to overcome the
unsatisfactory results caused by technical and tempera-
ture control-problems during the clinical use of the ﬁrst-
generation scanned-focused ultrasound systems [12, 13], a
new generation of focused ultrasound systems have been
built for MRI guidance and thermometry that are charac-
terized by long treatment times and small heated regions
[14, 15]. These systems are now being tested extensively for
variety of applications besides tumor ablation [16, 17], in-
cludinglocaldrugdelivery[18],controlofgenetherapy[19],
and blood-brain-barrier disruption [20].
From the clinical side, MRI-guided-focused ultrasound
has been approved by the Food and Drug Administration for
the treatment of uterine ﬁbroids [21, 22] and is in clinical
trials/investigation for ablation of brain tumors [23], breast
tumors [24, 25], liver tumors [26] and as a palliative of pain
caused by bone metastases [27].
All these possible clinical applications of MRI-guided-
focused ultrasound would greatly proﬁt from the develop-
ment of ultrasound treatment planning [8]. This planning
should accurately model (a) power deposition and acoustic2 The Scientiﬁc World Journal
energy absorption by the various tissues exposed to focused
ultrasound and (b) the resulting temperature and thermal
dose distribution in the treated area. Therefore, it should
be able to deal with the complex relation between focused
ultrasound system, perfusion, discrete vasculature, and
anatomy. This is an extremely complex task but it is essential
for optimizing the quality of focused ultrasound treatments.
We are particularly interested in the development of
techniques involving MRI-guided-focused ultrasound for
increasing local drug delivery. We have shown an increase
in tissue permeability when the temperature is kept just
below the threshold for thermal damage [18]. A region of
focal thermal ablation surrounded by an area of increased
tissue permeability with no apparent damage was observed
in these studies. The optimal control of temperature in
such a situation still remains a challenge. Our previous
studies have addressed the diﬃculties inherent in producing
uniformly low thermal doses when treating large regions
with a system having limited electronic steering [28]a n d
in capping thermal dose with temperature measurements
of limited spatial and temporal resolution [29]. Neither of
these studies considered the potential impact of vasculature
on the temperature achieved. This issue is addressed in the
present investigation. More speciﬁcally we have simulated
temperature increase and thermal dose deposition produced
by focused ultrasound treatments of a homogeneous block
of muscle-like tissue with either (i) one vessel, (ii) one-vessel
pair, or (iii) multiple vessel pairs.
Although several investigations (see e.g., [30]f o rac o m -
plete review) have considered the issue of blood ﬂow in ther-
mal treatments, our focus is to explicitly simulate diﬀerent
ultrasound delivery methods and to calculate the thermal
dose associated to each treatment when thermally signiﬁcant
blood vessel pairs are taken into account. These calculations
provide clear insights into the problems that need to be
solvedfortheoptimalcontrolofthermaldoseduringfocused
ultrasound treatments.
2.NumericalModel
In our computer simulations, we have employed the bioheat
transfer model developed by Lagendijk and coworkers [31–
34].Intheirmodel,thebioheattransferequationisseparated
into an equation valid for the tissue domain and an equation
valid for the vessel domain. These equations are coupled
through their common boundary (the blood vessel walls).
The tissue domain is described by the enhanced conductivity
equation
ρtcpt
∂T
∂t
=∇·(keﬀ∇T)+PFUS,( 1 )
where T is the temperature, ρt is the tissue mass density,
cpt is the tissue speciﬁc heat, PFUS is power per unit
volume produced by the external heating source (focused
ultrasound), and keﬀ is an eﬀective conductivity which takes
into account the presence of the smallest vessels that cannot
be possibly modeled individually. In the tissue domain,
we have solved (1) with the following parameters: ρt =
1000kg/m3, cpt = 4000JKg−1K−1,a n dkeﬀ = 1.8Wm−1 K−1
[35].
Inthevesseldomain,thefollowingheattransferequation
is solved:
ρbcpb
 
∂T
∂t
+v ·∇T
 
=∇·(kb∇T)+PFUS,( 2 )
where ρb is the blood mass density, cbt is the blood speciﬁc
heat,kb isthebloodheatconductivity,andv istheconvective
blood velocity. Since we are considering straight blood
vessels, (2) can be simpliﬁed as
ρbcpb
∂T
∂t
=∇·(kb∇T) −ρcpbw
∂T
∂z
+PFUS,( 3 )
where we have assumed ρb = 1060kg/m3, cpb =
3840JKg−1 K−1 and kb = 0.6Wm −1 K−1. The axial blood
velocity w (z-direction in our computational domain) is
given by
w = 2Vm
 
1 −
r2
R2
 
(4)
with Vm mean blood velocity, R vessel radius, and r radial
coordinate. The values for Vm and R have been taken
from the literature [36] and represent generic values for
representative vessels of a given size.
The power density distribution PFUS produced by the
focused ultrasound ﬁeld is modeled as described in [16]
PFUS = P0A(x,Rx)A
 
y,Ry
 
A(z,Rz) (5)
with A an expression of the type
A(u,Ru) = exp
 
−ln(2)
u2
R2
u
 
,( 6 )
where the coeﬃcients Ru are obtained by the half-power
width and height and P0 is the power density (Wcm−3).
These values are usually estimated experimentally.
Equations (1)a n d( 3)–(6) have been solved using the
ﬁnite element method on a geometry consisting of a block of
muscle-like tissue containing either (i) one blood vessel, (ii)
an artery-vein pair system, or (iii) a multiple set of artery-
vein pairs. The ﬁnite element method has been implemented
through COMSOL Multiphysics 3.5a and Matlab R2009b
and subject to the following boundary conditions. For
the tissue domain, the boundaries are related to the core
temperature (37◦C) by a ﬁxed heat transfer coeﬃcient h
simulating a few centimeters of tissue with h = keﬀ/d and
d the tissue thickness. The temperature at the vessel inlet is
assumed to be 37◦C and a convective heat ﬂux is assumed at
the outlet of the vessels. The initial temperature at t = 0i s
assumed to be 37◦C.
The overall performance of the ultrasound treatments is
evaluated by calculating the thermal dose for the midplane
of the computational domain. The thermal dose is calculated
using the empirical relationship introduced by Sapareto and
Dewey [37]
TD(t) =
  t
0
R(Tref−T(t ))dt ,( 7 )The Scientiﬁc World Journal 3
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Figure 1: Axial symmetrical temperature increase reached at the
end of a 60s insonation period in a large artery (R = 1.5mm,
L = 200mm, Vm = 13cm/s). The ultrasound beam is directed
downward and the blood ﬂow is moving upward.
where Tref is the reference temperature. A temperature of
43◦C was chosen as reference temperature since it is com-
monly used in reporting experimental thermal data. The
value of R (isodose constant) given by
R =
⎧
⎨
⎩
0.25 T(t) < 43
◦C,
0.5 T(t) ≥ 43
◦C
(8)
was chosen based on experimented data [37–39]. The
boundary of an isothermal dose value of 240min at the
reference temperature of 43◦C was selected to predict the
size of the necrosed tissue volume in muscle [38, 40]. All
thermal dose calculations are normalized to this standard in
this study, with a thermal dose of one corresponding to the
condition that will lead to 100% tissue necrosis.
3. NumericalResults
3.1. Single Vessel and Focused Ultrasound. To begin with, we
have investigated the eﬀect of vessel size and ﬂow velocity
on the temperature distribution during a focused ultrasound
exposure of a single straight blood vessel.
Initially, we considered a large straight artery with radius
R = 1.5mm, length L = 200mm, and mean ﬂow velocity
Vm = 13cm/s [36] running along the axial direction of
the transducer with the ultrasound focus at the blood vessel
center and the blood ﬂow opposite to the ultrasound beam
propagation (Figure 1). In this geometry, the model can be
solved using axial symmetry, which simpliﬁes the simula-
tions.
This is the worst case scenario since the blood ﬂow takes
away the heat generated inside the vessel. For the pur-
pose of illustration, we assumed the following ultrasound
parameters: focus half-power width 4mm, height 30mm,
and peak power density I0 = 15W/cm3. These values are
similar to the ones reported in [41]. As expected, Figure 1
shows that even after one minute of insonation, the blood
temperature increase remains low and the heat propagation
is not symmetrical because of the blood ﬂow presence.
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Figure 2: Axial symmetrical temperature increase reached at the
end of a 60s insonation period in a primary artery (R = 0.5mm,
L = 100mm, Vm = 8cm/s). The ultrasound beam is directed
downward and the blood ﬂow is moving upward.
T h es a m ec a l c u l a t i o n sh a v eb e e nr e p e a t e df o ram a i n
branch of a large artery (primary artery) with radius R =
0.5mm, length L = 100mm, and mean velocity Vm = 8cm/s
[36]. As may be seen in Figure 2, the heating in the focal
region after one minute of insonation is much higher than
the one shown in Figure 1 for the largest vessel. In Figure 3,
we plotted the temperature increase as a function of time for
points which are on the vessel wall and 1mm away from the
vessel.Thesepointsareatthefocalplane(z = L/2 = 50mm),
10mm below (far ﬁeld), and 10mm above it (near ﬁeld).
Sustained heating is obtained at the vessel wall in the focal
plane and 10mm above the focal plane, at the risk, however,
of having possible thermal damage 1mm from the vessel
wall.
If we consider a secondary branch with typical values
R = 0.3mm, L = 40mm, and Vm = 8cm/s [36], the
cooling eﬀect exerted by blood ﬂow is not as important as
for the previous two cases. After one-minute insonation at
thesameexposureconditionsasinFigures1and2,theblood
temperature increase is signiﬁcant at least at the focal plane
and above it as may be seen in Figure 4.
When the ultrasound focus is not at the vessel center
and/or the vessel makes an angle diﬀerent from zero with
the axial direction of the transducer, the axial symmetry is
lost and a full 3D simulation has to be preformed. When
the focus is not inside the vessel, temperatures favorable
to thermal ablation can be easily reached. These ideas are
illustrated in Figure 5. The plots in this ﬁgure have been
obtained assuming the large artery to be at the center of a
simulation domain having dimensions 60 × 60 × 40mm3.
When the focus is 1mm from the vessel wall, thermal
ablation conditions are easily reached at the focal plane
even for the largest vessel as may be seen in Figure 5(a),
where the temperature increase at the focus has been plotted
as a function of time for a 60s insonation period. For
comparison, the temperature at the focus without the vessel
and the temperature on the vessel wall at the focal plane
have been also plotted. In Figure 5(a), the parameters are the4 The Scientiﬁc World Journal
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Figure 3:Temperatureincreaseasafunctionoftimeforpoints(a)onthevesselwalland(b)1mmawaythevesselwall.Thevesselparameters
and ultrasound parameters are as in Figure 2 (primary artery). For each plot, the points are on the focal plane (z = L/2 = 50mm), 10mm
below, and 10mm above it.
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Figure 4: Axial symmetrical temperature increase reached at the
end of a 60s insonation period in a secondary artery (R = 0.3mm,
L = 40mm, Vm = 8cm/s). The ultrasound beam is directed
downward and the blood ﬂow is moving upward.
same as for Figure 1 except for the position of the focus that
is 1mm away from the vessel wall rather than at the vessel
center.
Figure 5(b) shows the temperature increase as a function
of time when the vessel makes an angle of 90◦ with the
direction of propagation of the ultrasound beam. All the
other parameters are the same as in Figure 1. The peak-
temperature increase at the end of the insonation period is
just a bit higher than the one with the vessel parallel to the
z direction; however planes above and below the focal planes
haveamuchhighertemperature.Asimilarresultisobtained,
for example, when the vessel makes an angle of 45◦ with the
z axis, that is, thermal ablation conditions are present above
andbelowthefocalplaneandmuchsmallertemperaturesare
seen in the focal plane (data not shown).
3.2. Artery-Vein Vessel Pair and Focused Ultrasound. Up to
the level of arterioles, venules and capillaries, and with
the exception of the superﬁcial venous system, vessels run
in counterﬂow pairs and therefore it is very important
to consider artery-vein vessel pair systems. In this study,
however, we will limit our discussion to the geometry
illustrated in Figure 6. The two vessels in Figure 6 represent
an artery and a vein in a counterﬂow situation with vessel
parameters typical of large arteries: R = 1.5mmandVm =
13cm/s. In Figure 6, the focus is at the center location of
the model block and at distance of one mm from each
of the vessels. The presence of the two vessels signiﬁcantly
restricts the propagation of heat along the x direction and
aﬀects the overall temperature distribution in the focal
region. For example, after one minute of insonation the peak
temperature increase at the focal plane is about 35% lower
than with no vessels present in the model and 38% lower
1cm above and below the focal plane.
When the focus is at one of the vessel centers, the peak
temperature increase in the focal region is similar to the
one obtained when one single vessel is present (Figure 1).The Scientiﬁc World Journal 5
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Figure 5: Temperature increase as a function of time for points 1mm away from the vessel wall. The vessel and ultrasound parameters are
as in Figure 1 (large artery), except that in (a) the position of the ultrasound focus is 1mm away from the vessel wall and in (b) the vessel
makes an angle of 90◦C with the direction of propagation of the ultrasound ﬁeld. The plots have been obtained through a full 3D simulation.
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Figure 6: Temperature increase reached at the end of a 60s in-
sonation period at the focal plane for an artery-vein vessel pair
and nearby tissue. The vessel and ultrasound parameters are the
same as in Figure 1 and the ultrasound focus is at the center of the
computational domain between the two vessels.
When the focus is 1mm away from only one of the vessel
walls, the situation is similar to the one described in
Figure 5(a).
Therefore, the presence of the pair introduces tempera-
ture inhomogeneity by cooling some areas in the focal region
while leaving some others unaﬀected.
3.3. Multiple Vessel Pairs and Focused Ultrasound. We have
investigatedamultipleartery-veinsystemlocatedinahomo-
geneousblockofmuscle-liketissuewithdimensions21×21×
26mm3. For the purpose of illustration, we have considered
the vessel pairs to run in parallel along the axial direction of
the transducer and having a radius of either 500μm( 3p a i r s )
or 400μm (6 pairs). These vessels are thermally signiﬁcant
according to [42–44]. The distance between the artery and
vein is 0.8mm for the 500μm pair and 0.6 for the 400μm
pair. The focus half-power width and height are assumed
to be, respectively, 3.2 and 24mm and the power density
distribution is varied during the treatment. The thermal
treatment of the multiple vessel system is simulated by an
ultrasound focus that is stepped through the midplane of
the computational domain using diﬀerent delivery methods.
The following delivery methods have been adopted: (i) the
focus is stepped through the midplane of the computational
domain in a random way to avoid thermal build-up, (ii) the
focus is stepped in a sequential manner, or (iii) the focus
is stepped through a spiral trajectory starting at the center
of the computational domain and going outward. In all the
three delivery methods, the number of insonations is 56 and
the duration time for each insonation is 20s followed by a 5s
cooling period for a total insonation time of 1395s, about 23
minutes.
Figure 7(a) shows the points through which the focus
is stepped for cases (i) and (ii). The points are separated
by a distance of 2mm. For case (i), the focus is stepped in6 The Scientiﬁc World Journal
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Figure 7: Points in the mid-plane of the computational domain
through which the focus is stepped either in (a) a random way or
sequential way, or (b) following a spiral trajectory.
a random way though the 56 points with the condition that
the distance between one insonation and the next is at least
8mm. For case (ii) the focus is stepped in a sequential way
starting from the top left square.
In the spiral trajectory case (iii), illustrated in
Figure 7(b), the distance between two successive turns is
2mm and also the distance between two successive insona-
tion points is 2mm.
Figure 8 shows examples of temperature distribution
in the midplane at the end of various insonation periods
for the random insonation treatment. In Figure 8(a) the
temperature distribution reached at the end of the ﬁrst
insonation period may be seen. The ﬁnal peak temperature
increase is about 16◦C and the temperature distribution is
distorted by the presence of a nearby vessel pair. Figure 8(b)
illustrates the temperature distribution reached at the end
of the second cooling period. The ﬁnal peak temperature
increase is about 8◦C and the heat propagation is inﬂuenced
by the presence of the vessel pairs that represent a barrier to
heat propagation.
0
10
20
20
10
0
0
10
20
0
2
4
6
8
10
12
14
16
y (mm) x (mm)
z
(
m
m
)
ΔT(◦C)
Time = 20 s
(a)
0
10
20
26
20
10
0 0
10
20
0
1
2
3
4
5
6
7
8
y (mm) x (mm)
z
(
m
m
)
ΔT(◦C)
Time = 50 s
(b)
Figure 8: Temperature distribution reached in the midplane for the
multiple artery-vein vessel pairs at the end of the ﬁrst insonation
period (a) and at the end of the second cooling period (b) for
the random insonation treatment with peak power density of
17.5W/cm3. The other parameters are illustrated in the text.
Wehavethencalculatedthethermaldoseinthemidplane
of the computational domain for cases (i), (ii), and (iii).
At ﬁrst, we have kept the power density distribution ﬁxed
during the treatments with a peak power of 16.5 W/cm3.
In Figure 9(a), the thermal dose for the entire treatment for
case (i) is shown. In this ﬁgure and in the following ones,
the color bar gives the values of the thermal dose normalized
with respect to the isothermal dose value of 240min
which is the threshold for tissue necrosis as described in
Section 2. Figures 10(a) and 11(a) show the equivalent plots
for cases (ii) and (iii). As may be seen in these plots,
when the power is kept ﬁxed during the treatments, the
thermal dose deposition varies greatly from one delivery
method to the other with the highest peak thermal dose
deposition observed for the spiral treatment. In all the
treatments, underdosage around the vessel pairs is clearlyThe Scientiﬁc World Journal 7
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Figure 9: Total thermal dose accumulation in the midplane for the
random insonation treatment (a) with ﬁxed power and (b) with
variable power.
visible. The mean thermal doses are, respectively, for case
(i) the mean is 1.07 and the standard deviation 0.65; case
(ii) the mean is 3.2 and standard deviation 3.0; case (iii) the
mean is 3.5 and standard deviation 3.2. These mean values
have been obtained by averaging the thermal dose values
above 0.3 in order to avoid the cooler regions inside the
vessels.
In addition, we have manually changed the power distri-
bution so that the peak thermal dose deposition remains in
the range between 230 to 250min for each insonation, with
the aim of simulating a controlled feedback situation. The
results of the simulations are given in Figures 9(b), 10(b),
11(b), respectively, for cases (i), (ii), and (iii). For case (i),
the total peak thermal dose is 1.6 and the mean and standard
deviation are, respectively, 0.8 and 0.2. For case (ii), the total
peak thermal dose is 1.6 and the mean and the standard
deviation are, respectively, 0.81 and 0.3. For case (iii), the
total peak thermal dose is 1.5 and the mean and standard
deviation are, respectively, 0.8 and 0.2. All these values have
been calculated considering only thermal dose values above
0.3, as above. Hence, when the power is changed during the
treatments, the thermal dose deposition is similar in all the
three cases and the delivery method does not appear to be as
important asin the examples with ﬁxed power. Furthermore,
the thermal dose is more uniform than when the power is
kept ﬁxed. However, underdosage is still visible around the
vessel pairs.
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Figure 10:Totalthermaldoseaccumulationinthemidplaneforthe
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4. Discussion
Besides factors such as absorbed power, thermal conduc-
tivity, and speciﬁc heat, blood ﬂow is the main parameter
which determines temperature distribution in tissues. In
this study in order to describe the eﬀect of blood vessels
and blood ﬂow on the temperature and thermal dose
distribution reached during a focused ultrasound treatment,
we have employed the bioheat transfer model developed by
Lagendijk and co-workers. Models of the type proposed by
Lagendijk and coworkers that explicitly take into account
discrete blood vessels have been formulated in order to
predict more accurately the overall temperature distribution
inhomogeneity observed in clinical practice. This temper-
ature inhomogeneity cannot be predicted with the more
popular Pennes bioheat equation [45]. In Pennes equation,
the inﬂuence of the blood ﬂow is taken into account by a
volumetric heat sink which assumes that the blood enters
the local tissue volume at the arterial temperature (about
37◦C in humans) and leaves the tissue at the local tissue
temperature. However, the assumption that all the tissue-
vascular heat exchange takes place in the capillary bed is
not correct [7, 46, 47]. Chen and Holmes [42]a n dC h a t o
[43] were the ﬁrst to point out that the thermal equilibration
process takes place not into the capillaries, as it was assumed
by Pennes, but in vessels with a diameter between 0.2 and
0.5mm. This fact has now been corroborated by several
authors.
Other discrete blood vessels models have been proposed;
see, for example, [47–51]. They mainly diﬀer for the heat
transfer equation in the tissue (in some models the Pennes’
equation is used rather than (1)) and the way in which the
vascular network is handled mathematically (with various
degrees of complexity) in (2). The main challenge for the
discrete vessel models is associated with solving (2) in the
vessel-network domain. The diﬃculty is not only related to
technical computer/software limitations but also with the
availability of patient speciﬁc data. Although advancements
in MRI/CT dynamic contrast imaging and MRI/CT angiog-
raphy have started providing speciﬁc patient data about
volumetric distribution of perfusion and morphology/ﬂow
rates of discrete vessels with increasing accuracy, they still
cannot provide information for the thermally signiﬁcant
vessels in the diameter range 0.3–0.8mm, required for a
more accurate evaluation of the temperature increase [44].
Our discrete blood vessel model is based on the one
described for scanned focused ultrasound hyperthermia
by Lagendijk and coworkers [32] with several diﬀerences
illustrated below. Contrary to [32], we have made no prior
assumption about the heat transfer coeﬃcient between
the tissue and the blood vessels; the continuity condition
applied at the boundary between the tissue domain and
the vessel domain implicitly models this. This is especially
importantwithpulsedfocusedultrasound,wheretheNusselt
number (ratio between the heat transfer coeﬃcient and
the conductive heat transfer coeﬃcient) is changing along
the blood vessel and also as a function of time. Most of
the discrete blood vessels models employ a Nusselt number
constant along the vessel to describe the heat transfer
between the ﬂowing blood and the tissue. The advantage of
assuming a constant Nusselt number is that it considerably
simpliﬁes the computational problem allowing the possibil-
ity of dealing with more complex vascular geometries than
the one considered here.
Atﬁrst,wehaveconsideredthesituationinwhichasingle
blood vessel is directly targeted, that is, the ultrasound focus
isatthevesselcenterandthevesselisalongtheaxialdirection
of the ultrasound ﬁeld (Figures 1–4). Kolios et al. [49]a n d
Lagendijk et al. [32] have considered similar situations using
a ﬁnite diﬀerence technique.
We have seen that the vessel size and blood ﬂow strongly
aﬀect the temperature reached at the vessel wall with the
largest vessels proving very diﬃcult to heat and the smallest
ones, less than 0.3mm in radius, heating easily to the
nearby tissue temperature. For suﬃciently long insonation
time, peak power, or ultrasound width and/or height, the
temperature at the vessel wall can be signiﬁcantly increased
at the cost of producing nearby regions of thermal damage.
When the focus is, for example, one mm from the vessel
wall(Figure 5(a)),temperaturesfavorabletothermaldamage
can be easily reached at the focal plane, but the temperature
distribution is highly inhomogeneous because of the blood
vessel presence. This situation remains true even when the
vessel makes an angle diﬀerent from zero with the axial
direction of the ultrasound ﬁeld. Since several thermally
signiﬁcant vessels run in counterﬂow pairs, we have consid-
ered a few examples of a single vessel pair (Figure 6). The
results are very similar to the ones obtained for a single vessel
with even a larger temperature heterogeneity caused by the
presence of two nearby blood vessels.
We have then simulated ultrasound treatments in a
homogeneous block of muscle-like tissue containing a set
of thermally signiﬁcant blood vessel pairs and calculated the
thermal dose associated with each treatment. In our plots,
the thermal dose has been normalized with respect to the
thermal dose of 240 equivalent minutes at 43◦C. In normal
thigh muscle in pig [38, 40], a dose threshold of 240 minutes
at 43◦C is considered adequate to coagulate all tissue, that
is, correspond to severe damage with 100% necrosis. For
minimal necrosis (partial damage) in normal thigh muscle,
a thermal dose of 31.2 equivalent minutes at 43◦Ch a sb e e n
reported in rabbit thigh muscle [52]. Therefore, a thermal
dose of 240 equivalent minutes at 43◦C can be considered as
a conservative estimate.
In general, studies have shown that that the threshold
for thermal damage (necrosis) in diﬀerent normal tissues
in various species including humans ranges from 20 to 240
equivalent minutes at 43◦C[ 38, 40]. Fewer studies have
considered the threshold for thermal damage on tumor
tissue (see e.g., [38, 53]). In [53], data from heating human
breast carcinomas and surrounding normal tissue have been
reported. The thermal dose required for inducing 50% of
tissue necrosis was calculated to be 116±31 equivalent min-
utes at 43◦C for the malignant tissue and 205±49 equivalent
minutes at 43◦C for normal tissue. Similarly, the thermal
dosesthatcauseddamageto50%ofthevesselswerefoundto
be, respectively, 63 ± 34 and 144 ± 46 equivalent minutes at
43◦C for the malignant and the normal vessels. Therefore,The Scientiﬁc World Journal 9
tissue and blood vessels in tumors seem to be more sen-
sitive to heat than is the surrounding normal tissue and
vessels.
In our simulations, we see that, when the treatments
are delivered without taking into account the cooling eﬀect
exerted by the blood ﬂow, the resulting thermal dose is
highly variable with regions of thermal damage, regions of
underdosage close to the vessels, and areas in between these
two extremes. This is true for all the three delivery meth-
ods examined in this investigation. However, the random
insonation treatment with ﬁxed power has a much lower
peak thermal dose, about 3 to 4 times smaller than the peak
thermal dose obtained with the sequential or spiral delivery
methods.
Whenthepowerwasadjustedsoastohaveathermaldose
accumulation at each insonation close to the threshold for
thermaldamage,theresultingtotalthermaldosedistribution
is more uniformly distributed in all three delivery methods.
Nevertheless, areas of thermal damage and underdosage are
still present. The average peak power and standard deviation
used in the treatments are, respectively, for case (i) 18.4 ±
3.8W / c m 3, for case (ii) 17.1 ± 3.9W / c m 3,a n df o rc a s e
(iii) 16.5 ± 4.1W / c m 3. Therefore, the random treatment
requires, on average, more power than the other two delivery
methods.
In principle, one could adjust the power at each in-
sonation so as to have peak values for the total thermal
dose below or close to one; however, this would be at the
risk of producing regions of underdosage. Since the power
required to keep the thermal dose close to the threshold for
thermal damage at each insonation varies greatly from one
insonation to next even for nearby points, only a treatment
planning able to predict the overall temperature distribution
as a function of acoustic energy absorption, blood vessel
position, and blood ﬂow would be able to produce the
required thermal dose distribution. Such a treatment plan-
ning would require the exact perfusion and the location of
the thermally signiﬁcant intermediate blood vessels (0.3–
0.8mm) of each individual patient. This information is
currently not available with the required resolution. To
compensate for this missing information, a thermal feedback
controlstrategycouldbeimplemented.Onepossiblestrategy
would be to perform a treatment of type (i) random pattern
t r e a t m e n to nag i v e ng r i da n da f t e rag i v e na m o u n to f
time to measure the temperature using MRI thermometry.
Regionswhosetemperatureriseisbelowagivensetthreshold
could undergo further treatment. This and other thermal
feedback control methods will greatly beneﬁt from an
improvementofthecurrentresolutionofMRIthermometry,
which is of the order of one mm while temperature het-
erogeneity is expected to be present at a level of about
0.3mm.
It is expected that a thermal feedback control strategy
wouldsigniﬁcantlyincreasethedurationofatreatmentsince
regions of underdosage would require a further treatment.
This shortcoming could be compensated with technolog-
ical advances able to speed up the movement and the
change of orientation of the transducer during the treat-
ment.
5. Conclusions
Several challenges need to be overcome in order to develop
a sound thermal treatment planning for focused ultrasound.
Even in the simpliﬁed situation discussed in this paper, we
have seen a wide variability in temperature/thermal dose dis-
tributionachieved,withregionsofbothunderdosagearound
the vessels and thermal damage in the same treatment.
The temperature increase in the tissue is determined by
the amount of ultrasound energy deposited and the amount
of tissue cooling by thermal conductance and blood ﬂow
convection. No matter which delivery method is chosen, the
only way to control temperature is to adjust the energy depo-
sition to compensateforthe presenceof thermallysigniﬁcant
vessels in the target area. By doing this, we have shown that it
is possible to reduce the temperature heterogeneity observed
in focused ultrasound thermal treatments.
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